Procaps S.A.
🚨 Critical Risk
FEI: 3008338784 • Barranquilla, Atlantico • COLOMBIA
FEI Number
3008338784
Location
Barranquilla, Atlantico
Country
COLOMBIAAddress
Calle 80 78b 201, , Barranquilla, Atlantico, Colombia
Critical Risk
FDA Import Risk Assessment
This firm has an extensive history of FDA import refusals with severe violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
MFR INSAN
The article is subject to refusal of admission pursuant to section 801(a)(1) in that the article appears to have been manufactured, processed, or packed under insanitary conditions.
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 9/29/2025 | 62GCE90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY) | Division of Southeast Imports (DSEI) | |
| 9/3/2025 | 61JCA16ROSUVASTATIN CALCIUM | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/17/2025 | 62TCY06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/13/2025 | 64LDK03BETAMETHASONE (GLUCOCORTICOID) | Division of Southeast Imports (DSEI) | |
| 4/10/2025 | 62GDJ90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/24/2025 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/22/2025 | 66VIY99MISCELLANEOUS PATENT MEDICINES, ETC. | Division of Southeast Imports (DSEI) | |
| 12/11/2024 | 65KDY08LATANOPROST (PROSTAGLANDIN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/2/2024 | 66JCY01LEVOTHYROXINE SODIUM (THYROID HORMONE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/4/2024 | 62TDB06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/12/2024 | 62TCC06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/5/2024 | 61XDY45CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/19/2023 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/31/2023 | 54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | 308MFR INSAN | Division of Northern Border Imports (DNBI) |
| 12/3/2021 | 62TDY06ESOMEPRAZOLE MAGNESIUM (ANTI-SECRETORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/3/2021 | 56YCE99ANTIBIOTIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/3/2021 | 62KCE11NITAZOXANIDE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/12/2021 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/11/2021 | 60ZDA15IVERMECTIN AND COMBINATIONS (ANTIPARASITIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/26/2021 | 60ZCA15IVERMECTIN AND COMBINATIONS (ANTIPARASITIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/9/2020 | 60LDY01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/4/2020 | 60RDA18ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/4/2020 | 64XDA11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/26/2020 | 64XCH11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/22/2020 | 64XCF11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/8/2020 | 64XDA11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/18/2020 | 61JCA16ROSUVASTATIN CALCIUM | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/26/2020 | 64XDH11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/23/2020 | 61JDA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/2/2020 | 64TDJ08TACROLIMUS (IMMUNOSUPPRESSIVE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/18/2020 | 64XDA11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/26/2019 | 64XDA11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/7/2019 | 61BDA02CYPROTERONE ACETATE (ANTI-ANDROGEN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/23/2019 | 64OCB01BELIMUMAB, MONOCLONAL ANTIBODIES | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/16/2019 | 56YCY99ANTIBIOTIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/20/2019 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/20/2019 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/30/2019 | 62GCA41IBUPROFEN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/13/2018 | 64GDY19ETHINYL ESTRADIOL (ESTROGEN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/30/2018 | 64GDB19ETHINYL ESTRADIOL (ESTROGEN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/8/2018 | 56JCJ99LINCOMYCIN N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/1/2017 | 61PCB26METFORMIN (ANTI-DIABETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/2/2017 | 54ABY13VITAMIN C (ASCORBIC ACID) | Division of Southeast Imports (DSEI) | |
| 6/4/2014 | 64XCH11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/30/2013 | 66NCF04RISPERIDONE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 54HIH03EVENING PRIMROSE OIL (FATS AND LIPID SUBSTANCES) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 62GIA41IBUPROFEN (ANTI-INFLAMMATORY) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 65PIA02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 62GIH41IBUPROFEN (ANTI-INFLAMMATORY) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 60LIH01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 65JIH31PROGESTERONE (PROGESTIN) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 61MIH41VALPROIC ACID (ANTI-CONVULSANT) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/6/2012 | 62AIH04CALCITRIOL (ANTI-HYPERCALCEMIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 9/9/2011 | 65JCA31PROGESTERONE (PROGESTIN) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 10/18/2007 | 61LCP99ANTI-COAGULANT, N.E.C. | New Orleans District Office (NOL-DO) | |
| 5/9/2007 | 64XCA11ISOTRETINOIN (KERATOLYTIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 11/25/2005 | 61LCB99ANTI-COAGULANT, N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 3/7/2005 | 64HBH02GUAIFENESIN (EXPECTORANT) | Division of Southeast Imports (DSEI) | |
| 2/14/2005 | 41CYY99FOODS (INCLUDING WATER) WITH EXCESSIVE NUTRITIONAL CLAIMS | 218LIST INGRE | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Procaps S.A.'s FDA import refusal history?
Procaps S.A. (FEI: 3008338784) has 59 FDA import refusal record(s) in our database, spanning from 2/14/2005 to 9/29/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Procaps S.A.'s FEI number is 3008338784.
What types of violations has Procaps S.A. received?
Procaps S.A. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Procaps S.A. come from?
All FDA import refusal data for Procaps S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.